Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study (Q44333531)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study |
scientific article |
Statements
1 reference
Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study (English)
1 reference
Irwin Goldstein
1 reference
Jay M Young
1 reference
Jerome Fischer
1 reference
Keith Bangerter
1 reference
Thomas Segerson
1 reference
Terry Taylor
1 reference
Vardenafil Diabetes Study Group
1 reference
1 March 2003
1 reference
1 reference
Identifiers
1 reference